JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilly, H.
Right arrow Articles by Kress, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilly, H.
Right arrow Articles by Kress, H. G.

Anesthesia & Analgesia, Vol 85, 149-154, Copyright © 1997 by International Anesthesia Research Society

GENERAL ARTICLES

Classification of malignant hyperthermia-equivocal patients by 4-chloro- M-cresol

H Gilly, I Musat, R Fricker, RE Bittner, K Steinbereithner and HG Kress
L. Boltzmann Institute for Experimental Anaesthesiology and Research in Intensive Care Medicine, and Department of Anaesthesiology and General Intensive Care B, University of Vienna, Austria. Hermann.Gilly@AKH- WIEN.AC.AT

To clarify the contracture response to 4-chloro-m-cresol (4-CmC) in malignant hyperthermia (MH) equivocal (MHE) muscle, we studied the effect of cumulative concentrations of 4-CmC. In vitro contracture test (IVCT) was performed in 35 probands according to the European MH test protocol. Surplus muscle bundles were exposed to 4-CmC (25-200 micromol/L), maintaining each concentration for 4 and 8 min. After 4 min exposure, the contracture increase of MH susceptible (MHS) (n = 7) muscle specimens was significantly (P = 0.05) greater at 50 micromol/L compared with either MHE halothane sensitive (MHEh) (n = 13) or MH normal (MHN) (n = 15) classified patients. Statistically significant differences (P < 0.05) were also found at 75 micromol/L. Exposure for 8 min yielded significant differences at 50 micromol/L only between MHS and MHEh. MHEh muscles revealed a dose-response curve similar to that found in MHN specimens. MHS muscles showed a significantly higher sensitivity to 4-CmC than either MHEh or MHN, and, in the probands tested so far, MHEh and MHN muscles seem to identically respond to 4- CmC, which seems to indicate a normal response in MHEh probands, implying no MH susceptibility. Therefore, 4-CmC might reduce the frequency of MHEh diagnosis based on standard halothane-caffeine IVCT. However, since MHE individuals may also represent an aberrant genetic status, with MH causing defects linked to unknown mutations, it is premature to consider 4-CmC as a solution to the diagnostic uncertainty of the true status of MHE probands. Presently, 4-CmC may provide supplementary information for a more precise phenotypic categorization of MHE individuals.


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
P. M. Hopkins
Malignant hyperthermia: advances in clinical management and diagnosis
Br. J. Anaesth., July 1, 2000; 85(1): 118 - 128.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
C. P. Baur, L. Bellon, P. Felleiter, M. Fiege, R. Fricker, K. Glahn, J. J. A. Heffron, A. Herrmann-Frank, K. Jurkat-Rott, W. Klingler, et al.
A Multicenter Study of 4-Chloro-m-cresol for Diagnosing Malignant Hyperthermia Susceptibility
Anesth. Analg., January 1, 2000; 90(1): 200 - 200.
[Abstract] [Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 1997 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1997 by the International Anesthesia Research Society.